These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27631440)

  • 1. [Not Available].
    Pulz S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2016 Sep; 51(9):514-5. PubMed ID: 27631440
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone.
    Lee CC; Lee MT; Chen YS; Lee SH; Chen YS; Chen SC; Chang SC
    JAMA Intern Med; 2015 Nov; 175(11):1839-47. PubMed ID: 26436523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Fluoroquinolones Have the Highest Risk of Aortic Aneurysm? A Case/Non-case Study in VigiBase®.
    Sommet A; Bénévent J; Rousseau V; Chebane L; Douros A; Montastruc JL; Montastruc F
    J Gen Intern Med; 2019 Apr; 34(4):502-503. PubMed ID: 30565153
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of aortic aneurysm and aortic dissection with the use of fluoroquinolones in Korea: a nested case-control study.
    Son N; Choi E; Chung SY; Han SY; Kim B
    BMC Cardiovasc Disord; 2022 Feb; 22(1):44. PubMed ID: 35152888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concerns About Fluoroquinolones and Aortic Aneurysm.
    Aschenbrenner DS
    Am J Nurs; 2021 May; 121(5):24. PubMed ID: 33872257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current progress of fluoroquinolones-increased risk of aortic aneurysm and dissection.
    Jun C; Fang B
    BMC Cardiovasc Disord; 2021 Sep; 21(1):470. PubMed ID: 34583637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic Dissection.
    Brown JP; Wing K; Leyrat C; Evans SJ; Mansfield KE; Wong AYS; Smeeth L; Galwey NW; Douglas IJ
    JAMA Cardiol; 2023 Sep; 8(9):865-870. PubMed ID: 37585175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between fluoroquinolones and the risk of aortic diseases: a meta-analysis of observational studies.
    Dai XC; Yang XX; Ma L; Tang GM; Pan YY; Hu HL
    BMC Cardiovasc Disord; 2020 Feb; 20(1):49. PubMed ID: 32013928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroquinolones and the Risk of Aortic Aneurysm or Aortic Dissection: A Systematic Review and Meta-Analysis.
    Rawla P; El Helou ML; Vellipuram AR
    Cardiovasc Hematol Agents Med Chem; 2019; 17(1):3-10. PubMed ID: 30947680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroquinolones and the risk of aortopathy: A systematic review and meta-analysis.
    Noman AT; Qazi AH; Alqasrawi M; Ayinde H; Tleyjeh IM; Lindower P; Bin Abdulhak AA
    Int J Cardiol; 2019 Jan; 274():299-302. PubMed ID: 30309682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serious side effects of fluoroquinolones: low risk of connective tissue-related disorders such as aneurysms].
    Boes J; Dofferhoff ASM; Fleuren HWHA; Kramers C
    Ned Tijdschr Geneeskd; 2020 Nov; 164():. PubMed ID: 33332024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between fluoroquinolones and aortic dissection and aortic aneurysms: a systematic review and meta-analysis.
    Wee I; Chin B; Syn N; Lee KS; Ng JJ; Choong AMTL
    Sci Rep; 2021 May; 11(1):11073. PubMed ID: 34040146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolones and the Risk of Aortopathy: A Systematic Review and Meta-Analysis.
    Latif A; Ahsan MJ; Kapoor V; Lateef N; Malik SU; Patel AD; Khan BA; Bittner M; Holmberg M
    WMJ; 2020 Sep; 119(3):185-189. PubMed ID: 33091293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population-based propensity score-matched cohort study.
    Garg M; Venugopalan V; Vouri SM; Diaby V; Iovine NM; Park H
    Pharmacotherapy; 2023 Sep; 43(9):883-893. PubMed ID: 37381584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks associated with the use of fluoroquinolones.
    DeLaney MC
    Br J Hosp Med (Lond); 2018 Oct; 79(10):552-555. PubMed ID: 30290736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Fluoroquinolones on Outcomes of Patients With Aortic Dissection or Aneurysm.
    Chen SW; Chan YH; Chien-Chia Wu V; Cheng YT; Chen DY; Lin CP; Hung KC; Chang SH; Chu PH; Chou AH
    J Am Coll Cardiol; 2021 Apr; 77(15):1875-1887. PubMed ID: 33858624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between fluoroquinolone and aortic aneurysm or dissection.
    Huh K; Kang M; Jung J
    Eur Heart J; 2023 Nov; 44(42):4476-4484. PubMed ID: 37724037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic Dissection and Aortic Aneurysms Associated with Fluoroquinolones: A Systematic Review and Meta-Analysis.
    Singh S; Nautiyal A
    Am J Med; 2017 Dec; 130(12):1449-1457.e9. PubMed ID: 28739200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolones and the risk of aortic aneurysm or aortic dissection: an updated systematic review and meta-analysis including 53,651,283 patients.
    Fatima K; Uzair SU; Salman A; Jawed A; Husain MA; Shah MG; Hasnain MA; Jawed A; Vohra LI; Lal PM
    Minerva Cardiol Angiol; 2023 Oct; 71(5):485-493. PubMed ID: 36468763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of aortic aneurysm and dissection following exposure to fluoroquinolones, common antibiotics, and febrile illness using a self-controlled case series study design: Retrospective analyses of three large healthcare databases in the US.
    Londhe AA; Holy CE; Weaver J; Fonseca S; Villasis A; Fife D
    PLoS One; 2021; 16(8):e0255887. PubMed ID: 34398907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.